Columbia University Multiple Sclerosis Center

New York, New York

Academic MS Center
6 Active TrialsInfusion CenterVirtual CareLarge Center
25 MS centers statewide · Ranked #3 in New York for clinical trials
What kind of place is this?
Comprehensive Care TeamResearch FocusedInfusion On-Site

You’re in an academic MS center that brings together specialists, testing, and treatment in one place. You’ll likely appreciate the on-site infusion services, broad support for symptoms and rehabilitation, and the option for virtual visits. Because this is a large single-location center, it may feel busier than a small neighborhood clinic.

Facility Profile
Synthesized from this facility's public website and data sources. Not a recommendation or ranking — just a summary to help you orient.
Direct Doctor Access2/5
Support Services5/5
Clinical Trials & Research4/5
Insurance & Navigation Help2/5
Scheduling & Virtual Care3/5

About Columbia University Multiple Sclerosis Center

Columbia combines MS care with a broad academic neurology team and on-site infusion services. It also offers pediatric and adult MS care under one program.

This center cares for people with multiple sclerosis, demyelinating diseases, and related neuroimmune disorders, including both children and adults. You can access diagnostic testing, disease-modifying therapy, outpatient infusions, plasma exchange, rehabilitation services, and support for vision, bladder, pain, mood, and thinking concerns. The team includes adult and pediatric neurologists, nurse practitioners, neuro-ophthalmologists, psychiatrists, neuropsychologists, and rehabilitation specialists. Patients can also use virtual visits and a patient portal.

Columbia University Multiple Sclerosis Center is an academic MS center in New York City connected to Columbia University Irving Medical Center and NewYork-Presbyterian/Columbia University Irving Medical Center. Patients can receive MS diagnosis, treatment, infusion therapy, rehabilitation support, and help with related symptoms in one multidisciplinary setting. The center also serves both pediatric and adult patients.

Specialized Programs

Pediatric and adult MS care
Clinical trial and research program
Neuro-ophthalmology
Physiatry and rehabilitation support
Pain management
Speech and swallowing support

Services & Treatments

What They Treat
Multiple sclerosisRelated neuroimmune disordersPediatric multiple sclerosisAdult multiple sclerosisDemyelinating diseases
How They Treat It
Comprehensive diagnostic evaluationsOngoing education and counselingDisease-modifying therapy treatmentInjection trainingSymptomatic therapyOutpatient infusion servicesClinical trial and research programMRINeuro-ophthalmology evaluationsVisual and brainstem auditory evoked potentialsOcular coherence tomographyEvaluation and treatment of bowel and bladder symptomsPhysiatry evaluationsPhysical therapyOccupational therapyNeuropsychological testingPsychiatry referralsPsychology referralsPain managementSpeech therapyPlasma exchangeDisease-modifying therapiesSymptomatic therapiesOutpatient infusion servicesPlasma exchangeIntravenous steroidsPhysical therapyOccupational therapySpeech therapyPsychiatryPsychologyPain management
Diagnostics
Comprehensive diagnostic evaluationsMRIVisual evoked potentialsBrainstem auditory evoked potentialsOcular coherence tomographyNeuropsychological testing

Research & Clinical Trials

This center is currently involved in 6 clinical trials — ranked #3 in New York for active trials

A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis
Hoffmann-La Roche
ACTIVE NOT RECRUITINGPHASE3
FenebrutinibOcrelizumabPlacebo matched to ocrelizumabPlacebo matched to fenebrutinib
A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
RECRUITINGPHASE1
CC-97540FludarabineCyclophosphamide
Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis
Sanofi
RECRUITINGPHASE3
FrexalimabPlaceboMRI contrast-enhancing agents
Genes and Environment in Multiple Sclerosis
Columbia University
RECRUITING
Study of COYA 302 for the Treatment of ALS
Coya Therapeutics
RECRUITINGPHASE2
COYA 302Placebo
Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial
Johns Hopkins University
ACTIVE NOT RECRUITINGNA
Natalizumab/natalizumab-sztn, Alemtuzumab, Ocrelizumab, Rituximab/rituximab-arrx/rituximab-abbs/rituximab-pvvr, Cladribine, Ofatumumab, Ublituximab-xiiy, Ocrelizumab and hyaluronidase-ocsqGlatiramer acetate, Interferons (intramuscular, subcutaneous, pegylated) Teriflunomide, Fumarates (dimethyl, diroximel, monomethyl) Fingolimod, Siponimod, Ozanimod, Ponesimod

Insurance & Access

Contact
710 W 168th Street, New York, NY 10032
Insurance & Support

FAQs from Columbia University Multiple Sclerosis Center

Yes. The center provides pediatric and adult MS care, with both adult and pediatric neurologists on the multidisciplinary team.

Yes. The center offers outpatient infusion services on-site, and plasma exchange is also among the services provided.

Patients can receive comprehensive diagnostic evaluations, MRI, visual evoked potentials, brainstem auditory evoked potentials, ocular coherence tomography, and neuropsychological testing.

Yes. Virtual visits are available by scheduling through the provider’s office.

The center offers second-opinion care, along with disease-modifying therapies, symptom treatment, rehabilitation support, and referrals for psychiatry, psychology, and pain management when needed.

Check out the MS Buddy App

Track symptoms, monitor wellness, and stay on top of your MS care. It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.

Download on the App StoreGet it on Google Play
Call Website